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Abstract
Background: Resistance exercise is known to be effective in reducing glycated haemoglobin (HbA1c) in people
with type 2 diabetes. However, studies, so far, have employed supervised resistance exercise in a laboratory or gym
facility which limits the future translation of such exercise in to clinical practice and recommendations. Our primary
aim, therefore, is to test the hypothesis, in a randomized controlled trial, that home-based resistance exercise
training and gym-based resistance exercise training both reduce HbA1c levels in people with type 2 diabetes
compared to control. We will also investigate the effects of home- and gym-based resistance exercise training on
muscle strength and body composition.
Methods: The current study is a three-arm randomised controlled trial which will be conducted with 150 eligible
people with type 2 diabetes to compare home-and gym-based resistance exercise training with usual care in
Kuwait. The interventions will be delivered by exercise specialists and last for 32 weeks. The primary outcomes are
HbA1c with secondary outcomes measuring muscle function, body composition, physical activity and quality of life.
Discussion: Ethical approval has been granted by the Dasman Diabetes Institute ethical review committee (RA/
197/2019). Study findings will be disseminated through presentation at scientific conferences and in scientific
journals.
Trial registration: NCT04136730: Retrospectively registered on 21 October 2019
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Introduction
Background and rationale {6a}
The main role of muscle is to allow body movements via
the generation of force, with the importance of this
highlighted in conditions associated with muscle mass
loss, such as sarcopenia [1]. Additionally, skeletal muscle
has a critical, but often overlooked, role in metabolism
[2]. For example, skeletal muscle is the primary protein
store in the body, and during starvation [3] or
conditions such as acquired immune deficiency
syndrome (AIDS), can provide gluconeogenic precursors
which are crucial for survival [4]. On top of this, as
muscle is the primary site for glucose disposal in the
body, it is therefore important in metabolic conditions
such as diabetes [5]. Extending this further, the
association of muscle in lifelong health is reflected by
data demonstrating the association of muscle mass/
function with mortality. This is highlighted by our
recent work where we demonstrated, in ~ 500,000
participants (40–69 years) from the UK Biobank, that
each 5 kg lower grip strength was associated with a
higher risk of all-cause mortality [HR (95% CI) men 1.16
(1.15 to 1.17) and women 1.20 (1.17 to 1.23)] as well as
a broad variety of other health outcomes [6]. Similarly,
we have demonstrated that the increased risk of all-
cause and CVD mortality in people with type 2 diabetes
(T2D) is attenuated in those with high grip strength
(CVD mortality with low [HR (95% CI) 4.05 (2.7 to
5.80)] vs high [HR 1.46 (0.87 to 2.46)], both relative to
people without T2D with low grip strength) [7]. Taking
this evidence together, this indicates that the mainten-
ance of muscular mass and strength is of clear import-
ance for public health.
Muscle strength is determined through a combination
of multiple modifiable and non-modifiable factors. The
primary modifiable factors are genetics with data indi-
cating that hand grip strength is ~ 50% hereditable [8].
On the non-modifiable side, the primary factors import-
ant for the maintenance of muscle mass/strength are nu-
trition, particularly sufficient protein intake (e.g., [9]),
and physical activity, particularly resistance exercise
which is even effective in nonagenarians [10]. Resistance
exercise has been shown, in a wide variety of popula-
tions, to be efficacious in increasing muscle mass and
function, increasing basal metabolic rate, reducing blood
pressure, improving blood lipids and glycaemic control
[11]. Indeed, a meta-analysis in 2011 found that resist-
ance exercise training can result in a 0.6% reduction in
HbA1c in people with type 2 diabetes [12].
It is clear, therefore, that targeting increased muscle
mass via resistance exercise may be effective in
improving glycaemic control in people with type 2
diabetes, yet very few people participate in such exercise
[13, 14]. One barrier to participation in resistance
exercise is that access to equipment in specialised
exercise facilities is required. This is a particular
problem for resistance exercise, with aerobic exercise
activities, such as walking/jogging, freely accessible to all
without any training or expensive equipment. The
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majority of studies, which have demonstrated the
efficacy of resistance exercise in reducing HbA1c, have
been carried out in specialised exercise facilities/
laboratories with each session supervised by a qualified
instructor. There is the need, therefore, to develop a
resistance exercise programme that is more accessible to
the wider population. To date, little is known about the
effectiveness or feasibility of home-based resistance
training, without supervision, in people with type 2
diabetes.
Objectives {7}
Our primary aim is to test the hypothesis, in a
randomized controlled trial, that home-based resistance
exercise training and gym-based resistance exercise
training both reduce HbA1c levels in people with type 2
diabetes compared to control. We will also investigate
the effects of home- and gym-based resistance exercise
training on muscle strength and body composition.
Trial design {8}
The current study is a three-arm randomised controlled
trial comparing usual care plus home- or gym-based re-
sistance exercise training interventions versus a usual
care control group maintaining habitual physical activity
levels. Eligible participants will be identified from clinics
and via adverts places locally and on social media and
we anticipate recruiting 150 participants with type 2 dia-
betes to the study. Baseline data will be measured prior
to randomisation, and follow-up data will be collected
16 weeks and 32 weeks after randomisation adjusted for
any delays in the start of the intervention post-
randomisation.
Methods: participants, interventions and
outcomes
Study setting {9}
This is a single-centre, DASMAN diabetes institute,
three-arm randomised controlled trial.
Eligibility criteria {10}
Potential participants will receive a mailed prestudy
invite which will provide details on study information
and details around eligibility. If still interested, potential
participants will be invited to the research site where
eligibility will be determined based on the inclusion and
exclusion criteria (Table 1).
Who will take informed consent? {26a}
Written consent will be obtained by a member of the
study team during a visit to the research site for the
baseline assessment, with no study procedures taking
place until consent has been obtained. At the baseline
visit, a member of the study team will confirm eligibility.
Additional consent provisions for collection and use of
participant data and biological specimens {26b}
Not applicable
Interventions
Explanation for the choice of comparators {6b}
Following the baseline assessment, patients will be
randomised to the home- or gym-based resistance exer-
cise group or the control group (1:1:1 ratio) using a
computer generated randomisation sequence. Random-
isation will be stratified by sex.
Intervention description {11a}
Control
Patients in the control group will receive usual clinical
care and will be instructed to maintain their normal
dietary and physical activity habits.
Home-based resistance exercise
Participants assigned to the home-based resistance exer-
cise group will be asked to perform exercises 3 times a
week for the intervention period. Each session will begin
with a 5-min warm-up and end with a 5-min cool-down,
walking on the spot/stretching. Exercises will target all
major muscle groups. The exercises will be press-ups,
band lateral raises, band seated low row, squat, lunge,
calf raise, and plank. The order of each session will be
(1) squat, (2) press up, (3) calf raise, (4) band seated low
row, (5) lunge, (6) band lateral raise and (7) plank.
Where participants are unable to perform any of the ex-
ercises, suitable alternatives will be sought.
Table 1 Inclusion and exclusion criteria
In order to be considered eligible for participation in the study they
must:
Criterion Characteristic of eligible participants
1 Be male or female aged ≥ 21 years at time of consent
2 Have physician diagnosed type 2 diabetes (HbA1c of 48
mmol/mol or over)
3 Have had no changes in anti-diabetic medication in the last 3
months
4 Have a BMI < 5 kg m−2
5 Have a blood pressure < 160/100mmHg
6 Not be receiving insulin therapy
7 No currently, or in the last year, be participating in any
vigorous aerobic activity (> 1 h per week)—defined a activity
requiring a large amount of effort which causes rapid
breathing and a substantial increase in heart rate
8 Not currently be participating in any resistance exercise
training
9 Be a Kuwaiti resident
10 Not have any other condition that prevents exercising safely
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The first 3 sessions of the exercise will be
performed, within our exercise facility, under the
supervision of a qualified exercise specialist to ensure
that the participants are comfortable with the
exercises and are performing them appropriately.
During these sessions, participants will perform 5–10
repetitions of each exercise (tiring but comfortably
achievable). A similar session, within the gym facility,
will take place at week 4 and then every 4 weeks of
the study to overcome any issues with the exercises
and to ensure progression to an appropriate intensity.
In weeks 2–4, participants will perform, during each
session, a single set of each exercise with this set
performed to voluntary muscular failure—defined as
not being able to perform another repetition. In
weeks 5–8, this will progress to 2 sets of each
exercise with both sets performed to voluntary
muscular failure, in each session. In weeks 9–32, 3
sets of each exercise will be performed with all sets
to voluntary muscular failure, in each session. When
multiple sets (weeks 5 onwards) of each exercise are
performed, these will be sequentially with 2 min rest
between each set.
Gym-based resistance exercise
Participants assigned to the gym-based resistance exer-
cise group will undertake 3 supervised sessions per week.
Each session will begin with a 5-min warm-up and end
with a 5-min cool-down, walking or cycling and stretch-
ing. The exercises performed during each session will
consist of leg press, calf press, leg curl, chest press, lat-
eral raise, seated row, and plank. The order of the ses-
sion will be (1) leg press, (2) chest press, (3) calf press,
(4) seated row, (5) leg curl, (6) lateral raise and (7) plank.
Where participants are unable to perform any of the ex-
ercises, suitable alternatives will be sought.
Exercises will be performed at 65–80% one repetition
maximum (1RM), and this will be re-tested every 4 weeks
of the intervention and the load adjusted accordingly. In
week 1, participants will perform, during each session, a
single set of 5–10 repetitions of each exercise (tiring but
comfortably achievable) to ensure they are comfortable
with the exercises and are performing these in the correct
form. In weeks 2–4, participants will perform, during each
session, a single set of each exercise with this set per-
formed to voluntary muscular failure—defined as not
being able to perform single another repetition. In weeks
5–8, this will progress to 2 sets of each exercise with both
sets performed to voluntary muscular failure, in each ses-
sion. In weeks 9–32, 3 sets of each exercise will be per-
formed with all sets performed to voluntary muscular
failure, in each session. When multiple sets (weeks 5 on-
wards) of each exercise are performed, these will be se-
quentially with 2min rest between each set.
Criteria for discontinuing or modifying allocated
interventions {11b}
If patients are not able to carry out any of the exercise,
then the trainers will work with the patient to develop a
suitable alternative exercise.
Strategies to improve adherence to interventions {11c}
For participants in the home-based group, the trainer
will send a message to each participant on the day of
their training session to remind them to carry out the
exercise and to respond to say they have done it. An ex-
ercise log will also be provided for participants.
Those in the gym-based group will be sent a reminder
message to ensure attendance at the supervised exercise
sessions within our gym facility.
Relevant concomitant care permitted or prohibited
during the trial {11d}
Usual clinical care will be maintained for all patients
during the trial.
Provisions for post-trial care {30}
Usual clinical care will be maintained for all patients
following completion of the trial.
Outcomes {12}
Baseline characteristics will be collected—age, sex, blood
pressure, duration of diabetes, current medications,
current comorbidities and blood lipids.
All outcomes measures will be assessed at baseline, 16
weeks and 32 weeks in all participants.
Primary outcome measure
The primary outcome measure is change in HbA1c from
baseline to 32 weeks.
Secondary outcome measures
Secondary outcome measures are achieved:
DEXA (GE, Lunar body composition scan) derived
whole body and regional lean mass.
Functional abilities as assessed by the short
performance physical battery test [15].
Grip strength (measured 3 times in each hand using a
Jamar Dynamometer)
One repetition maximum for leg extension and lateral
pull down.
Number of push-ups (full or on knees) completed.
DEXA derived fat mass and distribution.
Physical activity levels measured by wrist-worn acceler-
ometer (GENEActiv) for 7 days.
Quality of life: EQ-5D-DL questionnaire.
Current medications.
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Blood samples will also be stored for potential
measurement of other biomarkers of interest.
Optional sub-study
Participants will also have the option to have liver fat
measured by MRI and also 5-day continuous glucose
monitoring.
Qualitative evaluation
A sub-group of participants will be invited for qualitative
interviews at weeks 16 and 32 with an equal number of
participants (n = 15) from each of the home- and gym-
based resistance exercise groups. Participants will be in-
vited to take part once they have left or completed the
study and semi-structured interviews will take place at the
Dasman Diabetes Institute (DDI) in person. All interviews
will be audio-recorded and transcribed verbatim, anon-
ymised during transcription and checked for accuracy.
Participants’ experiences and the acceptability of the
interventions along with barriers and facilitators will be
explored using principles of grounded theory.
Participant timeline {13}
The schedule of enrolement, interventions and assessments
for participants is shown in Fig. 1.
Sample size {14}
Previous research has shown that resistance exercise
training can result in an ~ 0.6% decrease in HbA1c [12],
with a 0.5% in HbA1c also being classified as a clinically
relevant change. To detect a 0.5% decrease in HbA1c
(standard deviation within groups 0.79%) in the home-
based group or gym group versus control, we would re-
quire 40 participants per group at 80% power at the 5%
significance level. We will recruit 50 to each group to ac-
count for drop out.
Recruitment {15}
People with type 2 diabetes will be recruited:
 From DDI by usual care dieticians, physicians,
nurses and trainers.
 Using advertisements via multiple media outlets that
include texts, WhatsApp, flyers, social media and
posters. These will target potential participants,
primary health care centres and hospitals. Some
advertisements will be designed by the public
relations team at DDI.
Assignment of interventions: allocation
Sequence generation {16a}
Following the baseline assessment, patients will be
randomised to the home- or gym-based resistance exer-
cise group or the control group (1:1:1 ratio) using a
computer-generated randomisation sequence. Random-
isation will be stratified by sex.
Concealment mechanism {16b}
Blinding of patients and research staff to the
interventions is not possible but the staff and patients
will be blinded to the sequence and all data will be
analysed blind to allocation.
Implementation {16c}
The allocation sequence will be generated within the
electronic database (www.castoredc.com). Patients will
be enrolled by a member of the research team.
Assignment of interventions: blinding
Who will be blinded {17a}
Blinding of patients and research staff to the
interventions is not possible but all data will be analysed
blind to allocation.
Procedure for unblinding if needed {17b}
The current study design is open label with no blinding,
and thus, unblinding will not occur.
Data collection and management
Plans for assessment and collection of outcomes {18a}
All outcome data will be collected according to
developed standard operating procedures.
Plans to promote participant retention and complete
follow-up {18b}
No further strategies, than those described to maintain
engagement with intervention, are planned.
Data management {19}
All data will be kept in a secure storage area with access
only to the study staff or on an online database (www.
castoredc.com).
Confidentiality {27}
Access to the collated participants’ data will be restricted
to the principal investigator and appropriate research
study staff as required. All laboratory samples,
completed forms, reports and other records will be
identified using a unique participant ID number to
maintain participant confidentiality.
Plans for collection, laboratory evaluation and storage of
biological specimens for genetic or molecular analysis in
this trial/future use {33}
Blood samples will be collected via venepuncture and
analysed in our clinical biochemistry laboratories.
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Statistical methods
Statistical methods for primary and secondary outcomes
{20a}
All statistical analyses will be carried out according to
a detailed Statistical Analysis Plan, to be finalised
prior to database lock. We will use an intention to
treat approach for analysis, using baseline observation
carried forward for those who do not attend the 16
weeks visit, and last observation carried forward at
the 32 week visit. This will estimate the effect of the
interventions. The primary (and secondary) outcomes
(all continuous) will be analysed in a hierarchical
fashion, first analysing the change in outcome in the
gym-based group versus control at 16 weeks at 5%
level of significance; this is the group we hypothesise
will have the greatest effect size. If this first difference
is found to be significant, the home-based group will
also be compared to control at the 5% level, and if
Fig. 1 Schedule of Enrolement, Interventions and Assessments
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this is significant, the gym-based group will be com-
pared to the home-based group at the 5% level. The
overall type I error will not exceed 5% for each out-
come because of the hierarchical nature of the testing.
Comparison of the randomised groups at 32 weeks
will be conducted in a similar fashion, as a secondary
analysis, at the 5% level. As a secondary analysis, we
will conduct a per protocol ‘completer’s analyses’ of
those who attended at least the 16-week visits (irre-
spective of their protocol adherence or other charac-
teristics after randomisation). This is a less
conservative estimate of the effect of the intervention.
Finally, in the per protocol group, we will also inves-
tigate the association and correlation of change in
HbA1C with change in secondary outcomes.
Interim analyses {21b}
No interim analysis is planned in the current study.
Methods for additional analyses (e.g., subgroup analyses)
{20b}
No additional analyses are planned for the current study.
Methods in analysis to handle protocol non-adherence
and any statistical methods to handle missing data {20c}
Non-adherence will be handled through the use of
intention to treat analysis in the primary analysis.
Missing data will be handled by baseline observation
carried forward in the primary analysis. Due to the
randomised design, multivariable models will not be
used to adjust for confounding, and therefore
missing covariates will not impact the primary
analysis.
Plans to give access to the full protocol, participant level-
data and statistical code {31c}
The data sets analysed and the codes used for these
analyses are available from the corresponding author on
reasonable request.
Oversight and monitoring
Composition of the coordinating Centre and trial steering
committee {5d}
Principal investigator
Design and conduct of trial
Preparation of protocol and revision
Preparation of study materials and case report forms
Organise steering committee meetings
Publication of study reports
Steering committee (see title page for members)
Agreement of final protocol
All lead investigators will be members
Recruitment of patients and liasing with principal
investigators
Reviewing progress of study and if needed agreeing
changes to protocol




Responsible for trial master file
Budget control
Data verification
Composition of the data monitoring committee, its role
and reporting structure {21a}
Not applicable.
Adverse event reporting and harms {22}
There are unlikely to be major safety issues with our
proposed non-pharmacological interventions. How-
ever, if any safety concerns or incidents arise, we
will follow our standard operating procedures for
reporting adverse events in a non-Clinical Trial of
an Investigational Medicinal Product (non-CTIMP)
studies.
Frequency and plans for auditing trial conduct {23}
Formal audits will occur every 6 months.
Plans for communicating important protocol
amendments to relevant parties (e.g. trial participants,
ethical committees) {25}
Any amendments to the protocol will be approved by
the local ethics committee prior to implementation. All
investigators and patients enrolled in the trial will be
informed.
Dissemination plans {31a}
The study findings will be disseminated primarily via
conference presentations and scientific papers.
Discussion
The current trial is a single-centre, three-arm rando-
mised controlled trail. It has been designed to test
the effectiveness of home- and gym-based resistance
exercise training over a period of 32 weeks in people
with type 2 diabetes. It is known that resistance exer-
cise training can effectively reduce HbA1c in people
with type 2 diabetes [12] and the current study will
answer whether delivery of such an intervention with-
out regular supervision and outside of a gym-based
facility is also effective, potentially allowing a more
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pragmatic delivery of resistance exercise within clin-
ical practice.
Trial status
The study began recruitment in August 2019 and will be
ongoing until August 2020 (anticipated). Current
protocol: version 2 (04.09.2019).
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